FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma.
Huang J, Tsang WY, Fang XN, Zhang Y, Luo J, Gong LQ, Zhang BF, Wong CN, Li ZH, Liu BL, Huang JL, Yang YM, Liu S, Ban LX, Chan YH, Guan XY.
Huang J, et al. Among authors: tsang wy.
Cancer Res. 2024 Mar 15;84(6):855-871. doi: 10.1158/0008-5472.CAN-23-0966.
Cancer Res. 2024.
PMID: 38486485